$28.31
1.083.97%
At close: -
$28.06
-0.25-0.88%
After Hours: 7:59 PM EDT
Comments
Loading...
Hims & Hers Health Analyst Ratings and Price Targets | NYSE:HIMS | Benzinga
Hims & Hers Health Inc has a consensus price target of $29.32 based on the ratings of 20 analysts. The high is $68 issued by Canaccord Genuity on February 19, 2025. The low is $6 issued by Piper Sandler on May 26, 2022. The 3 most-recent analyst ratings were released by Truist Securities, B of A Securities, and B of A Securities on April 10, 2025, March 18, 2025, and March 6, 2025, respectively. With an average price target of $25.33 between Truist Securities, B of A Securities, and B of A Securities, there's an implied -9.72% downside for Hims & Hers Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
B of A Securities
Citigroup
Leerink Partners
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Hims & Hers Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/10/2025 | Buy Now | 17.61% | Truist Securities | Jailendra Singh39% | $39 → $33 | Maintains | Hold | Get Alert |
| 03/18/2025 | Buy Now | -21.6% | B of A Securities | Allen Lutz61% | $21 → $22 | Maintains | Underperform | Get Alert |
| 03/06/2025 | Buy Now | -25.16% | B of A Securities | Allen Lutz61% | $21 → $21 | Reiterates | Underperform → Underperform | Get Alert |
| 03/06/2025 | Buy Now | -3.78% | Citigroup | Daniel Grosslight43% | $27 → $27 | Reiterates | Sell → Sell | Get Alert |
| 02/26/2025 | Buy Now | 38.99% | Truist Securities | Jailendra Singh39% | $24 → $39 | Maintains | Hold | Get Alert |
| 02/25/2025 | Buy Now | 42.55% | Leerink Partners | Michael Cherny78% | $24 → $40 | Maintains | Market Perform | Get Alert |
| 02/25/2025 | Buy Now | 24.73% | Piper Sandler | Korinne Wolfmeyer47% | $24 → $35 | Maintains | Neutral | Get Alert |
| 02/25/2025 | Buy Now | 117.39% | Needham | Ryan MacDonald57% | $31 → $61 | Maintains | Buy | Get Alert |
| 02/25/2025 | Buy Now | -3.78% | Citigroup | Daniel Grosslight43% | $25 → $27 | Maintains | Sell | Get Alert |
| 02/20/2025 | Buy Now | -25.16% | B of A Securities | Allen Lutz61% | $18 → $21 | Maintains | Underperform | Get Alert |
| 02/19/2025 | Buy Now | 142.34% | Canaccord Genuity | Maria Ripps69% | $38 → $68 | Maintains | Buy | Get Alert |
| 02/18/2025 | Buy Now | 113.83% | Morgan Stanley | Craig Hettenbach60% | $42 → $60 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/10/2025 | Buy Now | -10.91% | Citigroup | Daniel Grosslight43% | $24 → $25 | Downgrade | Neutral → Sell | Get Alert |
| 01/07/2025 | Buy Now | 24.73% | BTIG | David Larsen43% | → $35 | Initiates | → Buy | Get Alert |
| 01/06/2025 | Buy Now | -14.47% | Piper Sandler | Korinne Wolfmeyer47% | $21 → $24 | Maintains | Neutral | Get Alert |
| 01/06/2025 | Buy Now | 10.48% | Needham | Ryan MacDonald57% | $28 → $31 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | 49.68% | Morgan Stanley | Craig Hettenbach60% | → $42 | Initiates | → Overweight | Get Alert |
| 12/02/2024 | Buy Now | 35.42% | Canaccord Genuity | Maria Ripps69% | $28 → $38 | Maintains | Buy | Get Alert |
| 11/20/2024 | Buy Now | -0.21% | TD Cowen | Jonna Kim45% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | Buy Now | -35.85% | B of A Securities | Allen Lutz61% | $32 → $18 | Downgrade | Buy → Underperform | Get Alert |
| 11/08/2024 | Buy Now | -0.21% | TD Cowen | Jonna Kim45% | $25 → $28 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | -3.78% | Deutsche Bank | George Hill63% | $23 → $27 | Maintains | Hold | Get Alert |
| 11/05/2024 | Buy Now | -25.16% | Piper Sandler | Korinne Wolfmeyer47% | $18 → $21 | Reiterates | Neutral → Neutral | Get Alert |
| 11/05/2024 | Buy Now | -0.21% | Canaccord Genuity | Maria Ripps69% | $24 → $28 | Maintains | Buy | Get Alert |
| 10/21/2024 | Buy Now | -10.91% | B of A Securities | Michael Cherny78% | $23 → $25 | Maintains | Buy | Get Alert |
| 10/14/2024 | Buy Now | -18.03% | B of A Securities | Michael Cherny78% | $20 → $23 | Maintains | Buy | Get Alert |
| 09/13/2024 | Buy Now | -28.72% | B of A Securities | Michael Cherny78% | $24 → $20 | Maintains | Buy | Get Alert |
| 08/22/2024 | Buy Now | -14.47% | Needham | Ryan MacDonald57% | → $24 | Initiates | → Buy | Get Alert |
| 08/07/2024 | Buy Now | -18.03% | Deutsche Bank | George Hill63% | $16 → $23 | Maintains | Hold | Get Alert |
| 08/06/2024 | Buy Now | -35.85% | Piper Sandler | Korinne Wolfmeyer47% | $18 → $18 | Reiterates | Neutral → Neutral | Get Alert |
| 07/18/2024 | Buy Now | -18.03% | Truist Securities | Jailendra Singh39% | $13 → $23 | Maintains | Hold | Get Alert |
| 07/11/2024 | Buy Now | -10.91% | TD Cowen | Jonna Kim45% | $15 → $25 | Maintains | Buy | Get Alert |
| 07/11/2024 | Buy Now | -35.85% | Piper Sandler | Korinne Wolfmeyer47% | $16 → $18 | Maintains | Neutral | Get Alert |
| 06/27/2024 | Buy Now | -18.03% | Jefferies | Glen Santangelo50% | $14 → $23 | Maintains | Hold | Get Alert |
| 06/13/2024 | Buy Now | -7.34% | B of A Securities | Michael Cherny78% | $22 → $26 | Maintains | Buy | Get Alert |
| 06/03/2024 | Buy Now | -21.6% | B of A Securities | Michael Cherny78% | $17.25 → $22 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | -14.47% | Canaccord Genuity | Maria Ripps69% | $20 → $24 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | -28.72% | Citigroup | Daniel Grosslight43% | $16 → $20 | Downgrade | Buy → Neutral | Get Alert |
| 05/07/2024 | Buy Now | -42.98% | Deutsche Bank | George Hill63% | $14 → $16 | Maintains | Hold | Get Alert |
| 05/07/2024 | Buy Now | -53.67% | Piper Sandler | Korinne Wolfmeyer47% | $11 → $13 | Maintains | Neutral | Get Alert |
| 04/16/2024 | Buy Now | -46.54% | Jefferies | Glen Santangelo50% | $17 → $15 | Downgrade | Buy → Hold | Get Alert |
| 04/10/2024 | Buy Now | -28.72% | Canaccord Genuity | Maria Ripps69% | → $20 | Initiates | → Buy | Get Alert |
| 02/27/2024 | Buy Now | -39.42% | Guggenheim | Jack Wallace54% | $15 → $17 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | -42.98% | Citigroup | Daniel Grosslight43% | $12 → $16 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | -60.8% | Piper Sandler | Michael Lavery68% | $9 → $11 | Maintains | Neutral | Get Alert |
| 02/27/2024 | Buy Now | -53.67% | Truist Securities | Jailendra Singh39% | $10 → $13 | Maintains | Hold | Get Alert |
| 02/26/2024 | Buy Now | -64.36% | Leerink Partners | Michael Cherny78% | → $10 | Initiates | → Market Perform | Get Alert |
| 01/05/2024 | Buy Now | -46.54% | Tigress Financial | Ivan Feinseth71% | $14 → $15 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | -64.36% | Truist Securities | Jailendra Singh39% | $12 → $10 | Maintains | Hold | Get Alert |
| 08/08/2023 | Buy Now | -50.11% | Credit Suisse | Jonathan Yong66% | → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 07/28/2023 | Buy Now | -60.8% | TD Cowen | Jonna Kim45% | → $11 | Initiates | → Outperform | Get Alert |
| 06/15/2023 | Buy Now | -50.11% | Tigress Financial | Ivan Feinseth71% | $12 → $14 | Reiterates | → Buy | Get Alert |
| 05/30/2023 | Buy Now | -60.8% | Piper Sandler | Michael Lavery68% | $12 → $11 | Maintains | Neutral | Get Alert |
| 05/09/2023 | Buy Now | -46.54% | B of A Securities | Michael Cherny78% | $13.5 → $15 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | -57.23% | Piper Sandler | Michael Lavery68% | $11 → $12 | Maintains | Neutral | Get Alert |
| 04/27/2023 | Buy Now | -35.85% | Guggenheim | Jack Wallace54% | $15 → $18 | Maintains | Buy | Get Alert |
| 04/26/2023 | Buy Now | -60.8% | Piper Sandler | Korinne Wolfmeyer47% | $10 → $11 | Maintains | Neutral | Get Alert |
| 04/11/2023 | Buy Now | -64.36% | Baird | Vikram Kesavabhotla46% | → $10 | Initiates | → Neutral | Get Alert |
| 03/01/2023 | Buy Now | -50.11% | Credit Suisse | Jonathan Yong66% | $8 → $14 | Maintains | Outperform | Get Alert |
| 02/28/2023 | Buy Now | -46.54% | Guggenheim | Jack Wallace54% | → $15 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | Buy Now | -57.23% | Truist Securities | Jailendra Singh39% | $7 → $12 | Maintains | Hold | Get Alert |
| 02/28/2023 | Buy Now | -50.11% | Citigroup | Daniel Grosslight43% | $9 → $14 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | -64.36% | Piper Sandler | Korinne Wolfmeyer47% | $7 → $10 | Maintains | Neutral | Get Alert |
| 02/28/2023 | Buy Now | -51.89% | B of A Securities | Michael Cherny78% | $11.5 → $13.5 | Maintains | Buy | Get Alert |
| 02/09/2023 | Buy Now | -60.8% | Jefferies | Glen Santangelo50% | $7 → $11 | Upgrade | Hold → Buy | Get Alert |
| 01/12/2023 | Buy Now | -57.23% | Tigress Financial | Ivan Feinseth71% | $11 → $12 | Maintains | Buy | Get Alert |
| 11/08/2022 | Buy Now | -69.71% | B of A Securities | Michael Cherny78% | $7.5 → $8.5 | Upgrade | Neutral → Buy | Get Alert |
| 11/08/2022 | Buy Now | — | SVB Leerink | Joy Zhang27% | — | Upgrade | Underperform → Market Perform | Get Alert |
| 10/17/2022 | Buy Now | -78.62% | Piper Sandler | Korinne Wolfmeyer47% | $8 → $6 | Downgrade | Overweight → Neutral | Get Alert |
| 09/07/2022 | Buy Now | -75.05% | Truist Securities | Jailendra Singh39% | → $7 | Initiates | → Hold | Get Alert |
| 08/10/2022 | Buy Now | -71.49% | Credit Suisse | Jonathan Yong66% | $7 → $8 | Maintains | Outperform | Get Alert |
| 08/09/2022 | Buy Now | -82.18% | SVB Leerink | Joy Zhang27% | $4 → $5 | Maintains | Underperform | Get Alert |
| 07/15/2022 | Buy Now | -85.74% | SVB Leerink | Joy Zhang27% | → $4 | Initiates | → Underperform | Get Alert |
| 05/26/2022 | Buy Now | -78.62% | Piper Sandler | Sean Wieland50% | $8 → $6 | Maintains | Overweight | Get Alert |
| 05/10/2022 | Buy Now | -78.62% | Citigroup | Daniel Grosslight43% | $9 → $6 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Hims & Hers Health (HIMS) stock?
The latest price target for Hims & Hers Health (NYSE:HIMS) was reported by Truist Securities on April 10, 2025. The analyst firm set a price target for $33.00 expecting HIMS to rise to within 12 months (a possible 17.61% upside). 41 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hims & Hers Health (HIMS)?
The latest analyst rating for Hims & Hers Health (NYSE:HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.
When was the last upgrade for Hims & Hers Health (HIMS)?
The last upgrade for Hims & Hers Health Inc happened on February 9, 2023 when Jefferies raised their price target to $11. Jefferies previously had a hold for Hims & Hers Health Inc.
When was the last downgrade for Hims & Hers Health (HIMS)?
The last downgrade for Hims & Hers Health Inc happened on February 18, 2025 when Morgan Stanley changed their price target from $42 to $60 for Hims & Hers Health Inc.
When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on April 10, 2025 so you should expect the next rating to be made available sometime around April 10, 2026.
Is the Analyst Rating Hims & Hers Health (HIMS) correct?
While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $39.00 to $33.00. The current price Hims & Hers Health (HIMS) is trading at is $28.06, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.